Xinnate AB
Skåne län
- UEI
- F95XL2NQUM73
- CAGE
- AYG6N
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Scheelevägen 2, 223 63 Lund, Sweden
- Website
- xinnate.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A unique treatment for prevention and treatment of infection and inflammation in pressure ulcers | Defense Health Agency | $1,769,676 |
Quick answers
Is Xinnate AB registered in SAM.gov?
Yes. Xinnate AB's SAM.gov registration is active through February 23, 2027.
What is Xinnate AB's most recent federal award?
Xinnate AB's most recent federal grant award is A unique treatment for prevention and treatment of infection and inflammation in pressure ulcers (W81XWH2210783), from Defense Health Agency, on September 15, 2022.
On GovTribe
See Xinnate AB's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors